Description

Ilumya is a medication used for the treatment of moderate to severe plaque psoriasis in adults. It works by targeting specific pathways in the immune system to reduce inflammation and the overproduction of skin cells.

Interpreter Notes

Interpreters should be aware that Ilumya may be referred to by its brand name or its active ingredient, tildrakizumab. It is important to maintain a formal register and avoid colloquial terms. Stick to the glossary term in clinical contexts to prevent confusion.

Example Sentences

EN: The doctor prescribed Ilumya to manage the patient's psoriasis symptoms.

ES: El médico recetó Ilumya para manejar los síntomas de psoriasis del paciente.

Common Interpreter Mistakes

Confusing Ilumya with other psoriasis treatments; using informal language when discussing medication; mispronouncing the active ingredient tildrakizumab.